Study on Qi Deficiency Syndrome Identification Modes of Coronary Heart Disease Based on Metabolomic Biomarkers

<table>CGMP <sup>1</sup>H-NMR spectra of CHD patients and healthy people.<i> Note</i>. (a) Healthy people; (b) CHD patients: 1: <i>α</i>-glucose, 2: <i>β</i>-glucose, 3: lactic acid, 4: creatine, 5: praline, 6: histidine, 7: choline, 8: aspartic acid, 9: methylamine, 10: carnitine, 11: acetone, 12: acetyl glutamic acid, 13: lysine, 14: alanine, 15: <i>β</i>-hydroxyisobutyric acid, 16: glutamine, 17: isoleucine, 18: tryptophan, 19: phenylalanine, 20: glutamate methylamine, 21: valine, and 22: leucine.</table>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Study on Qi Deficiency Syndrome Identification Modes of Coronary Heart Disease Based on Metabolomic Biomarkers 